Determinants of initial inhaled corticosteroid use in patients with GOLD A/B COPD: a retrospective study of UK general practice

Number of patients by therapy combination at COPD diagnosis (overall cohort). COPD chronic obstructive pulmonary disease, ICS inhaled corticosteroids, LABA long-acting beta-agonists, LAMA long-acting muscarinic antagonists, SABA short-acting beta-agonists, SAMA short-acting muscarinic antagonist